GlassScriptPhysician profile
James R Williamson
NPI 1457753840
$4,536.39
in general payments reported to CMS, 2019-2025
29 companies · $829 in 2025
The $829 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,861 · 2020: $75.76 · 2021: $212 · 2022: $652 · 2023: $534 · 2024: $374 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248 · Long Term Medical Supply Or Device Loan: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,248.34 |
| Long Term Medical Supply Or Device Loan | $487.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,493.00 | 2019 | |
| Integra Lifesciences Corporation | $750.04 | 2022-2025 | Amnioexcel Plus, Integra, Primatrix |
| Averitas Pharma INC. | $395.17 | 2023-2025 | Qutenza |
| Liberty Surgical INC. | $367.88 | 2019 | |
| Eclipse Technology Solutions INC. | $265.18 | 2022-2025 | |
| Grt US Holding, INC. | $233.19 | 2020-2022 | |
| Smith+Nephew, INC. | $189.54 | 2021-2024 | Stravix Pl, Stravix Mesh, Stravix |
| Organogenesis INC. | $163.53 | 2021-2025 | Puraply, Puraply Wound Matrix, Via Matrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $131.30 | 2022 | |
| Treace Medical Concepts, INC. | $59.63 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $52.26 | 2020-2025 | Nuzyra |
| Biotissue Holdings INC. | $50.66 | 2021-2022 | |
| Globus Medical, INC. | $45.76 | 2023 | Ankle Fracture System |
| Medical Device Business Services, INC. | $44.92 | 2022 | |
| Convatec INC. | $38.30 | 2023-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $31.05 | 2023 | Seglentis |
| Musculoskeletal Transplant Foundation INC. | $26.94 | 2022-2023 | |
| Stryker Corporation | $26.33 | 2023 | Easyfuse |
| Kerecis Limited | $22.79 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Reprise Biomedical, INC. | $21.64 | 2025 | Miro 3d, Miro3d |
| Cashflow Solutions, LLC | $16.42 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Depuy Synthes Sales INC. | $16.35 | 2022 | |
| Acera Surgical, INC. | $16.10 | 2022 | |
| Qol Medical, LLC | $14.52 | 2022 | |
| Amgen INC. | $14.00 | 2025 | Krystexxa |
| Alfasigma USA, INC. | $13.20 | 2022 | |
| Misonix INC | $12.89 | 2020 | |
| Zyla Life Sciences, INC. | $12.64 | 2020 | |
| Paragon 28, INC. | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Williamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.